Hepatology

The benefits of rifaximin use continues to gather momentum, given its well-tolerated side-effect profile, and these require consideration.

I think the underlying ethos of the ILC is that we want to bring together people who have an interest in improving the outcome of patients with liver disease…

The prevalence and prognostic relevance of cirrhotic cardiomyopathy (CCM), as defined according with the new core criteria proposed in 2019…

PICTURESQUE Geneva, Switzerland, encircling Lac Léman with the famous Jet d’Eau fountain and overlooked by the Alps, would have…

The truth is my interest and fascination for liver and hepatology was very much influenced by my father…

Non-alcoholic fatty liver disease (NAFLD) is becoming the most frequent cause of chronic liver disease worldwide. The stage of fibrosis…

THE INTERNATIONAL Liver Congress (ILC) 2021 of the The European Association for the Study of the Liver (EASL) invited three speakers…

Necrolytic acral erythema (NAE) was first described in 1996 by el Darouti and Abu el Ela in Egypt.1 It is most…